Resources | Press Releases |Press Release

LYNX Medical Systems, a Picis company, announced today that Picis LYNX E/Point® emergency department (ED) revenue management solution has achieved the Healthcare Financial Management Association’s (HFMA) prestigious Peer Review designation following an independent board review and thorough 11-step evaluation process. This designation was earned after demonstrating to respected members of the healthcare finance community that E/Point meets the stringent demands of today’s healthcare systems for effectiveness, quality and ease of use, price, proven value and superior customer and technical support.

Tweet this: E/Point, a revenue management solution from @PicisInc LYNX, has achieved Peer Review distinction from HFMA http://bit.ly/PicisNews

In today’s healthcare market, hospital administrators are challenged with shrinking operating margins, heightened payer scrutiny and increased pressures on quality and efficiency. E/Point helps relieve some of the increasing regulatory and financial pressures by helping healthcare organizations obtain optimal reimbursement for services provided, while delivering value through consistent and compliant charging.

E/Point is an easily-deployable SaaS solution that promotes consistent and compliant charging for procedures and facility visit levels based on the care provided in the ED. E/Point’s presenting problem-based methodology and charging algorithm is designed to comply with Outpatient Prospective Patient System (OPPS) guidelines and produces a visit level distribution to accurately reflect patient acuity mix and resource use, while providing consistent, compliant and defensible charges.

“With a customer retention rate averaging 97%, our customers recognize the value that our solutions deliver in meeting their revenue and compliance needs. We are equally excited to have earned HFMA Peer Review designation for E/Point as further validation of our success. It is very rewarding to have our solutions be formally recognized by revenue management and industry experts as achieving HFMA’s stringent requirements for effectiveness, quality and proven return on investment,” said Mike DeTolla, Senior Vice President, LYNX Medical Systems.

For more information about LYNX E/Point, visit http://www.lynxmed.com/products or stop by the LYNX booth #279 at HFMA’s 2010 Annual National Institute (ANI) Conference, June 20-23 in Nashville, Tennessee.

About LYNX Medical Systems, Inc.

LYNX Medical Systems, a Picis company, provides software and services that help healthcare organizations charge for and code emergency and clinic care. LYNX revenue management solutions help improve outpatient and inpatient clinical documentation, reduce compliance risk, and promote accurate and consistent code assignment for appropriate reimbursement. LYNX revenue management solutions currently help more than 600 hospitals manage more than 21 million patient encounters in the U.S. annually. For more information, visit http://www.lynxmed.com.

About HFMA

HFMA is the nation's leading membership organization for healthcare financial management executives and leaders. More than 35,000 members--ranging from CFOs to controllers to accountants--consider HFMA a respected thought leader on top trends and issues facing the healthcare industry. HFMA members can be found in all areas of the healthcare system, including hospitals, managed care organizations, physician practices, accounting firms, and insurance companies.

© 2010 Picis, Inc. All rights reserved. Picis and E/Point may be a trademark or registered trademark of Picis, Inc. or LYNX Medical Systems, Inc. in the United States and/or other countries. All other trademarks mentioned herein are the properties of their respective owners. This press release contains express or implied forward-looking statements relating to, among other things, Picis’ expectations concerning the functionality and market acceptance of its products, and management’s plans, objectives and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond Picis’ control, which could cause actual results to differ materially from those contemplated in these forward-looking statements.